These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 15352222)
1. 6-Hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression. Liang Q; Liou AK; Ding Y; Cao G; Xiao X; Perez RG; Chen J J Neurosci Res; 2004 Sep; 77(5):747-61. PubMed ID: 15352222 [TBL] [Abstract][Full Text] [Related]
2. p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. Izumi Y; Sawada H; Sakka N; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A J Neurosci Res; 2005 Mar; 79(6):849-60. PubMed ID: 15712215 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. Choi WS; Eom DS; Han BS; Kim WK; Han BH; Choi EJ; Oh TH; Markelonis GJ; Cho JW; Oh YJ J Biol Chem; 2004 May; 279(19):20451-60. PubMed ID: 14993216 [TBL] [Abstract][Full Text] [Related]
4. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Kaul S; Kanthasamy A; Kitazawa M; Anantharam V; Kanthasamy AG Eur J Neurosci; 2003 Sep; 18(6):1387-401. PubMed ID: 14511319 [TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models. Sun F; Anantharam V; Zhang D; Latchoumycandane C; Kanthasamy A; Kanthasamy AG Neurotoxicology; 2006 Sep; 27(5):807-15. PubMed ID: 16870259 [TBL] [Abstract][Full Text] [Related]
6. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. Han BS; Hong HS; Choi WS; Markelonis GJ; Oh TH; Oh YJ J Neurosci; 2003 Jun; 23(12):5069-78. PubMed ID: 12832530 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures. Ganser C; Papazoglou A; Just L; Nikkhah G Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824 [TBL] [Abstract][Full Text] [Related]
8. Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3. Ebert AD; Hann HJ; Bohn MC J Neurosci Res; 2008 Feb; 86(2):317-25. PubMed ID: 17787016 [TBL] [Abstract][Full Text] [Related]
9. Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha-synuclein. Zhou ZD; Yap BP; Gung AY; Leong SM; Ang ST; Lim TM Exp Cell Res; 2006 Jan; 312(2):156-70. PubMed ID: 16297908 [TBL] [Abstract][Full Text] [Related]
10. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. Choi WS; Yoon SY; Oh TH; Choi EJ; O'Malley KL; Oh YJ J Neurosci Res; 1999 Jul; 57(1):86-94. PubMed ID: 10397638 [TBL] [Abstract][Full Text] [Related]
11. Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. von Coelln R; Kügler S; Bähr M; Weller M; Dichgans J; Schulz JB J Neurochem; 2001 Apr; 77(1):263-73. PubMed ID: 11279282 [TBL] [Abstract][Full Text] [Related]
12. Characterization of MPP(+)-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins. Choi WS; Canzoniero LM; Sensi SL; O'Malley KL; Gwag BJ; Sohn S; Kim JE; Oh TH; Lee EB; Oh YJ Exp Neurol; 1999 Sep; 159(1):274-82. PubMed ID: 10486196 [TBL] [Abstract][Full Text] [Related]
13. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. Weng Z; Signore AP; Gao Y; Wang S; Zhang F; Hastings T; Yin XM; Chen J J Biol Chem; 2007 Nov; 282(47):34479-91. PubMed ID: 17895242 [TBL] [Abstract][Full Text] [Related]
14. A tetracycline-regulated adenovirus encoding dominant-negative caspase-9 is regulated in rat brain and protects against neurotoxin-induced cell death in vitro, but not in vivo. Ebert AD; Chen F; He X; Cryns VL; Bohn MC Exp Neurol; 2005 Feb; 191 Suppl 1():S80-94. PubMed ID: 15629764 [TBL] [Abstract][Full Text] [Related]
15. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation. Hurelbrink CB; Armstrong RJ; Luheshi LM; Dunnett SB; Rosser AE; Barker RA Exp Neurol; 2001 Sep; 171(1):46-58. PubMed ID: 11520120 [TBL] [Abstract][Full Text] [Related]
16. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma. Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway. Chu JM; Chen LW; Chan YS; Yung KK Neuropharmacology; 2011 Dec; 61(8):1389-98. PubMed ID: 21907219 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells. Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517 [TBL] [Abstract][Full Text] [Related]
19. Enhanced cystatin C and lysosomal protease expression following 6-hydroxydopamine exposure. Lee DC; Close FT; Goodman CB; Jackson IM; Wight-Mason C; Wells LM; Womble TA; Palm DE Neurotoxicology; 2006 Mar; 27(2):260-76. PubMed ID: 16414118 [TBL] [Abstract][Full Text] [Related]
20. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]